Global Intestinal Ascariasis Medicine Market Insights, Forecast to 2028

SKU ID :QYR-20380759 | Published Date: 03-Mar-2022 | No. of pages: 110
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Painkiller 1.2.3 Piperazine Citrate 1.2.4 Complication Treatment Drug 1.2.5 Others 1.3 Market by Application 1.3.1 Global Intestinal Ascariasis Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Patients With Ulcer Disease 1.3.3 Complication Treatment 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Intestinal Ascariasis Medicine Market Perspective (2017-2028) 2.2 Intestinal Ascariasis Medicine Growth Trends by Region 2.2.1 Intestinal Ascariasis Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Intestinal Ascariasis Medicine Historic Market Size by Region (2017-2022) 2.2.3 Intestinal Ascariasis Medicine Forecasted Market Size by Region (2023-2028) 2.3 Intestinal Ascariasis Medicine Market Dynamics 2.3.1 Intestinal Ascariasis Medicine Industry Trends 2.3.2 Intestinal Ascariasis Medicine Market Drivers 2.3.3 Intestinal Ascariasis Medicine Market Challenges 2.3.4 Intestinal Ascariasis Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Intestinal Ascariasis Medicine Players by Revenue 3.1.1 Global Top Intestinal Ascariasis Medicine Players by Revenue (2017-2022) 3.1.2 Global Intestinal Ascariasis Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Intestinal Ascariasis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Intestinal Ascariasis Medicine Revenue 3.4 Global Intestinal Ascariasis Medicine Market Concentration Ratio 3.4.1 Global Intestinal Ascariasis Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Intestinal Ascariasis Medicine Revenue in 2021 3.5 Intestinal Ascariasis Medicine Key Players Head office and Area Served 3.6 Key Players Intestinal Ascariasis Medicine Product Solution and Service 3.7 Date of Enter into Intestinal Ascariasis Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Intestinal Ascariasis Medicine Breakdown Data by Type 4.1 Global Intestinal Ascariasis Medicine Historic Market Size by Type (2017-2022) 4.2 Global Intestinal Ascariasis Medicine Forecasted Market Size by Type (2023-2028) 5 Intestinal Ascariasis Medicine Breakdown Data by Application 5.1 Global Intestinal Ascariasis Medicine Historic Market Size by Application (2017-2022) 5.2 Global Intestinal Ascariasis Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Intestinal Ascariasis Medicine Market Size (2017-2028) 6.2 North America Intestinal Ascariasis Medicine Market Size by Type 6.2.1 North America Intestinal Ascariasis Medicine Market Size by Type (2017-2022) 6.2.2 North America Intestinal Ascariasis Medicine Market Size by Type (2023-2028) 6.2.3 North America Intestinal Ascariasis Medicine Market Share by Type (2017-2028) 6.3 North America Intestinal Ascariasis Medicine Market Size by Application 6.3.1 North America Intestinal Ascariasis Medicine Market Size by Application (2017-2022) 6.3.2 North America Intestinal Ascariasis Medicine Market Size by Application (2023-2028) 6.3.3 North America Intestinal Ascariasis Medicine Market Share by Application (2017-2028) 6.4 North America Intestinal Ascariasis Medicine Market Size by Country 6.4.1 North America Intestinal Ascariasis Medicine Market Size by Country (2017-2022) 6.4.2 North America Intestinal Ascariasis Medicine Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Intestinal Ascariasis Medicine Market Size (2017-2028) 7.2 Europe Intestinal Ascariasis Medicine Market Size by Type 7.2.1 Europe Intestinal Ascariasis Medicine Market Size by Type (2017-2022) 7.2.2 Europe Intestinal Ascariasis Medicine Market Size by Type (2023-2028) 7.2.3 Europe Intestinal Ascariasis Medicine Market Share by Type (2017-2028) 7.3 Europe Intestinal Ascariasis Medicine Market Size by Application 7.3.1 Europe Intestinal Ascariasis Medicine Market Size by Application (2017-2022) 7.3.2 Europe Intestinal Ascariasis Medicine Market Size by Application (2023-2028) 7.3.3 Europe Intestinal Ascariasis Medicine Market Share by Application (2017-2028) 7.4 Europe Intestinal Ascariasis Medicine Market Size by Country 7.4.1 Europe Intestinal Ascariasis Medicine Market Size by Country (2017-2022) 7.4.2 Europe Intestinal Ascariasis Medicine Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Intestinal Ascariasis Medicine Market Size (2017-2028) 8.2 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Type 8.2.1 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Intestinal Ascariasis Medicine Market Share by Type (2017-2028) 8.3 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Application 8.3.1 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Intestinal Ascariasis Medicine Market Share by Application (2017-2028) 8.4 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region 8.4.1 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Intestinal Ascariasis Medicine Market Size (2017-2028) 9.2 Latin America Intestinal Ascariasis Medicine Market Size by Type 9.2.1 Latin America Intestinal Ascariasis Medicine Market Size by Type (2017-2022) 9.2.2 Latin America Intestinal Ascariasis Medicine Market Size by Type (2023-2028) 9.2.3 Latin America Intestinal Ascariasis Medicine Market Share by Type (2017-2028) 9.3 Latin America Intestinal Ascariasis Medicine Market Size by Application 9.3.1 Latin America Intestinal Ascariasis Medicine Market Size by Application (2017-2022) 9.3.2 Latin America Intestinal Ascariasis Medicine Market Size by Application (2023-2028) 9.3.3 Latin America Intestinal Ascariasis Medicine Market Share by Application (2017-2028) 9.4 Latin America Intestinal Ascariasis Medicine Market Size by Country 9.4.1 Latin America Intestinal Ascariasis Medicine Market Size by Country (2017-2022) 9.4.2 Latin America Intestinal Ascariasis Medicine Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Intestinal Ascariasis Medicine Market Size (2017-2028) 10.2 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Type 10.2.1 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Intestinal Ascariasis Medicine Market Share by Type (2017-2028) 10.3 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Application 10.3.1 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Intestinal Ascariasis Medicine Market Share by Application (2017-2028) 10.4 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country 10.4.1 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Intestinal Ascariasis Medicine Introduction 11.1.4 Pfizer Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.1.5 Pfizer Recent Developments 11.2 Actavis 11.2.1 Actavis Company Details 11.2.2 Actavis Business Overview 11.2.3 Actavis Intestinal Ascariasis Medicine Introduction 11.2.4 Actavis Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.2.5 Actavis Recent Developments 11.3 Henan Sino New Energy Material 11.3.1 Henan Sino New Energy Material Company Details 11.3.2 Henan Sino New Energy Material Business Overview 11.3.3 Henan Sino New Energy Material Intestinal Ascariasis Medicine Introduction 11.3.4 Henan Sino New Energy Material Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.3.5 Henan Sino New Energy Material Recent Developments 11.4 Bayer HealthCare 11.4.1 Bayer HealthCare Company Details 11.4.2 Bayer HealthCare Business Overview 11.4.3 Bayer HealthCare Intestinal Ascariasis Medicine Introduction 11.4.4 Bayer HealthCare Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.4.5 Bayer HealthCare Recent Developments 11.5 Bullvet 11.5.1 Bullvet Company Details 11.5.2 Bullvet Business Overview 11.5.3 Bullvet Intestinal Ascariasis Medicine Introduction 11.5.4 Bullvet Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.5.5 Bullvet Recent Developments 11.6 Inject Care Parenterals 11.6.1 Inject Care Parenterals Company Details 11.6.2 Inject Care Parenterals Business Overview 11.6.3 Inject Care Parenterals Intestinal Ascariasis Medicine Introduction 11.6.4 Inject Care Parenterals Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.6.5 Inject Care Parenterals Recent Developments 11.7 Endo Pharmaceuticals 11.7.1 Endo Pharmaceuticals Company Details 11.7.2 Endo Pharmaceuticals Business Overview 11.7.3 Endo Pharmaceuticals Intestinal Ascariasis Medicine Introduction 11.7.4 Endo Pharmaceuticals Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.7.5 Endo Pharmaceuticals Recent Developments 11.8 Sanofi 11.8.1 Sanofi Company Details 11.8.2 Sanofi Business Overview 11.8.3 Sanofi Intestinal Ascariasis Medicine Introduction 11.8.4 Sanofi Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.8.5 Sanofi Recent Developments 11.9 Purdue Pharma 11.9.1 Purdue Pharma Company Details 11.9.2 Purdue Pharma Business Overview 11.9.3 Purdue Pharma Intestinal Ascariasis Medicine Introduction 11.9.4 Purdue Pharma Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.9.5 Purdue Pharma Recent Developments 11.10 Novartis 11.10.1 Novartis Company Details 11.10.2 Novartis Business Overview 11.10.3 Novartis Intestinal Ascariasis Medicine Introduction 11.10.4 Novartis Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.10.5 Novartis Recent Developments 11.11 Johnson & Johnson 11.11.1 Johnson & Johnson Company Details 11.11.2 Johnson & Johnson Business Overview 11.11.3 Johnson & Johnson Intestinal Ascariasis Medicine Introduction 11.11.4 Johnson & Johnson Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.11.5 Johnson & Johnson Recent Developments 11.12 Cipla 11.12.1 Cipla Company Details 11.12.2 Cipla Business Overview 11.12.3 Cipla Intestinal Ascariasis Medicine Introduction 11.12.4 Cipla Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.12.5 Cipla Recent Developments 11.13 Sun Pharmaceutical Industries 11.13.1 Sun Pharmaceutical Industries Company Details 11.13.2 Sun Pharmaceutical Industries Business Overview 11.13.3 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Introduction 11.13.4 Sun Pharmaceutical Industries Revenue in Intestinal Ascariasis Medicine Business (2017-2022) 11.13.5 Sun Pharmaceutical Industries Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Painkiller Table 3. Key Players of Piperazine Citrate Table 4. Key Players of Complication Treatment Drug Table 5. Key Players of Others Table 6. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Intestinal Ascariasis Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Intestinal Ascariasis Medicine Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Intestinal Ascariasis Medicine Market Share by Region (2017-2022) Table 10. Global Intestinal Ascariasis Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Intestinal Ascariasis Medicine Market Share by Region (2023-2028) Table 12. Intestinal Ascariasis Medicine Market Trends Table 13. Intestinal Ascariasis Medicine Market Drivers Table 14. Intestinal Ascariasis Medicine Market Challenges Table 15. Intestinal Ascariasis Medicine Market Restraints Table 16. Global Intestinal Ascariasis Medicine Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Intestinal Ascariasis Medicine Revenue Share by Players (2017-2022) Table 18. Global Top Intestinal Ascariasis Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intestinal Ascariasis Medicine as of 2021) Table 19. Ranking of Global Top Intestinal Ascariasis Medicine Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Intestinal Ascariasis Medicine Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Intestinal Ascariasis Medicine Product Solution and Service Table 23. Date of Enter into Intestinal Ascariasis Medicine Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Intestinal Ascariasis Medicine Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2017-2022) Table 27. Global Intestinal Ascariasis Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2023-2028) Table 29. Global Intestinal Ascariasis Medicine Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Intestinal Ascariasis Medicine Revenue Share by Application (2017-2022) Table 31. Global Intestinal Ascariasis Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Intestinal Ascariasis Medicine Revenue Share by Application (2023-2028) Table 33. North America Intestinal Ascariasis Medicine Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Intestinal Ascariasis Medicine Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Intestinal Ascariasis Medicine Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Intestinal Ascariasis Medicine Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Intestinal Ascariasis Medicine Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Intestinal Ascariasis Medicine Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Intestinal Ascariasis Medicine Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Intestinal Ascariasis Medicine Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Intestinal Ascariasis Medicine Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Intestinal Ascariasis Medicine Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Intestinal Ascariasis Medicine Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Intestinal Ascariasis Medicine Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Intestinal Ascariasis Medicine Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Intestinal Ascariasis Medicine Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Intestinal Ascariasis Medicine Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Intestinal Ascariasis Medicine Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Intestinal Ascariasis Medicine Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Intestinal Ascariasis Medicine Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Intestinal Ascariasis Medicine Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Intestinal Ascariasis Medicine Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Intestinal Ascariasis Medicine Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Intestinal Ascariasis Medicine Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Intestinal Ascariasis Medicine Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Intestinal Ascariasis Medicine Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Intestinal Ascariasis Medicine Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Intestinal Ascariasis Medicine Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Intestinal Ascariasis Medicine Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Intestinal Ascariasis Medicine Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Intestinal Ascariasis Medicine Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Intestinal Ascariasis Medicine Market Size by Country (2023-2028) & (US$ Million) Table 63. Pfizer Company Details Table 64. Pfizer Business Overview Table 65. Pfizer Intestinal Ascariasis Medicine Product Table 66. Pfizer Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 67. Pfizer Recent Developments Table 68. Actavis Company Details Table 69. Actavis Business Overview Table 70. Actavis Intestinal Ascariasis Medicine Product Table 71. Actavis Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 72. Actavis Recent Developments Table 73. Henan Sino New Energy Material Company Details Table 74. Henan Sino New Energy Material Business Overview Table 75. Henan Sino New Energy Material Intestinal Ascariasis Medicine Product Table 76. Henan Sino New Energy Material Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 77. Henan Sino New Energy Material Recent Developments Table 78. Bayer HealthCare Company Details Table 79. Bayer HealthCare Business Overview Table 80. Bayer HealthCare Intestinal Ascariasis Medicine Product Table 81. Bayer HealthCare Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 82. Bayer HealthCare Recent Developments Table 83. Bullvet Company Details Table 84. Bullvet Business Overview Table 85. Bullvet Intestinal Ascariasis Medicine Product Table 86. Bullvet Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 87. Bullvet Recent Developments Table 88. Inject Care Parenterals Company Details Table 89. Inject Care Parenterals Business Overview Table 90. Inject Care Parenterals Intestinal Ascariasis Medicine Product Table 91. Inject Care Parenterals Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 92. Inject Care Parenterals Recent Developments Table 93. Endo Pharmaceuticals Company Details Table 94. Endo Pharmaceuticals Business Overview Table 95. Endo Pharmaceuticals Intestinal Ascariasis Medicine Product Table 96. Endo Pharmaceuticals Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 97. Endo Pharmaceuticals Recent Developments Table 98. Sanofi Company Details Table 99. Sanofi Business Overview Table 100. Sanofi Intestinal Ascariasis Medicine Product Table 101. Sanofi Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 102. Sanofi Recent Developments Table 103. Purdue Pharma Company Details Table 104. Purdue Pharma Business Overview Table 105. Purdue Pharma Intestinal Ascariasis Medicine Product Table 106. Purdue Pharma Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 107. Purdue Pharma Recent Developments Table 108. Novartis Company Details Table 109. Novartis Business Overview Table 110. Novartis Intestinal Ascariasis Medicine Product Table 111. Novartis Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 112. Novartis Recent Developments Table 113. Johnson & Johnson Company Details Table 114. Johnson & Johnson Business Overview Table 115. Johnson & Johnson Intestinal Ascariasis Medicine Product Table 116. Johnson & Johnson Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 117. Johnson & Johnson Recent Developments Table 118. Cipla Company Details Table 119. Cipla Business Overview Table 120. Cipla Intestinal Ascariasis Medicine Product Table 121. Cipla Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 122. Cipla Recent Developments Table 123. Sun Pharmaceutical Industries Company Details Table 124. Sun Pharmaceutical Industries Business Overview Table 125. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product Table 126. Sun Pharmaceutical Industries Revenue in Intestinal Ascariasis Medicine Business (2017-2022) & (US$ Million) Table 127. Sun Pharmaceutical Industries Recent Developments Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Global Intestinal Ascariasis Medicine Market Share by Type: 2021 VS 2028 Figure 2. Painkiller Features Figure 3. Piperazine Citrate Features Figure 4. Complication Treatment Drug Features Figure 5. Others Features Figure 6. Global Intestinal Ascariasis Medicine Market Share by Application: 2021 VS 2028 Figure 7. Patients With Ulcer Disease Case Studies Figure 8. Complication Treatment Case Studies Figure 9. Others Case Studies Figure 10. Intestinal Ascariasis Medicine Report Years Considered Figure 11. Global Intestinal Ascariasis Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Intestinal Ascariasis Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Intestinal Ascariasis Medicine Market Share by Region: 2021 VS 2028 Figure 14. Global Intestinal Ascariasis Medicine Market Share by Players in 2021 Figure 15. Global Top Intestinal Ascariasis Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intestinal Ascariasis Medicine as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Intestinal Ascariasis Medicine Revenue in 2021 Figure 17. North America Intestinal Ascariasis Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Intestinal Ascariasis Medicine Market Size Market Share by Type (2017-2028) Figure 19. North America Intestinal Ascariasis Medicine Market Size Market Share by Application (2017-2028) Figure 20. North America Intestinal Ascariasis Medicine Market Size Share by Country (2017-2028) Figure 21. United States Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Intestinal Ascariasis Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Intestinal Ascariasis Medicine Market Size Market Share by Type (2017-2028) Figure 25. Europe Intestinal Ascariasis Medicine Market Size Market Share by Application (2017-2028) Figure 26. Europe Intestinal Ascariasis Medicine Market Size Share by Country (2017-2028) Figure 27. Germany Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Intestinal Ascariasis Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Intestinal Ascariasis Medicine Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Intestinal Ascariasis Medicine Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Intestinal Ascariasis Medicine Market Size Share by Region (2017-2028) Figure 37. China Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Intestinal Ascariasis Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Intestinal Ascariasis Medicine Market Size Market Share by Type (2017-2028) Figure 45. Latin America Intestinal Ascariasis Medicine Market Size Market Share by Application (2017-2028) Figure 46. Latin America Intestinal Ascariasis Medicine Market Size Share by Country (2017-2028) Figure 47. Mexico Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Intestinal Ascariasis Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Intestinal Ascariasis Medicine Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Intestinal Ascariasis Medicine Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Intestinal Ascariasis Medicine Market Size Share by Country (2017-2028) Figure 53. Turkey Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Intestinal Ascariasis Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Pfizer Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 57. Actavis Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 58. Henan Sino New Energy Material Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 59. Bayer HealthCare Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 60. Bullvet Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 61. Inject Care Parenterals Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 62. Endo Pharmaceuticals Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 63. Sanofi Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 64. Purdue Pharma Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 65. Novartis Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 66. Johnson & Johnson Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 67. Cipla Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 68. Sun Pharmaceutical Industries Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2017-2022) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed
Pfizer Actavis Henan Sino New Energy Material Bayer HealthCare Bullvet Inject Care Parenterals Endo Pharmaceuticals Sanofi Purdue Pharma Novartis Johnson & Johnson Cipla Sun Pharmaceutical Industries
  • PRICE
  • $4900
    $9800
    $7350
    Buy Now

Our Clients